Skip to main content
SpringerLink
Log in

Prise den charge de la cardiopathie ischémique du sujet âgé fragile

  • Chapter
La personne âgée fragile

  • 655 Accesses

Abstrait

La prévalence des coronaropathies augmente avec l’âge. On retrouve en effet, après 75 ans plus de 20 % de coronariens. L’incidence de l’infarctus du myocarde est de 8 à 10 % après 80 ans, quand elle est inférieure à 2% avant 60 ans. Les sujets âgés ne sont pas uniquement plus souvent touchés par l’infarctus du myocarde que les sujets plus jeunes, ils le sont également plus sévèrement avec une mortalité multipliée par 3 après 75 ans.

K. Watson et al. Quality Indicators for the Care of Ischemic Heart Disease in Vulnerable Elders. JAGS 55:S366–S372, 2007.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Alexander KP, Roe MT, Chen AY et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005;46:1479–1487.

    Article  PubMed  Google Scholar 

  2. Collaborative overview of randomised trials of antiplatelet therapy: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994;308:81–106.

    Google Scholar 

  3. The RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827–830.

    Article  Google Scholar 

  4. Krumholz HM, Radford MJ, Wang Y et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998;280: 623–629.

    Article  PubMed  CAS  Google Scholar 

  5. Wulsin LR, Evans JC, Vasan RS et al. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med 2005;67:697–702.

    Article  PubMed  Google Scholar 

  6. Carney RM, Blumenthal JA, Freedland KE et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004;66:466–474.

    Article  PubMed  Google Scholar 

  7. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311–322.

    Google Scholar 

  8. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: A randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistrplase and of aspirin plus heparin vs. aspirin alone among 41,288 cases of suspected acute myocardial infarction. Lancet 1992;339: 753–770.

    Article  Google Scholar 

  9. Berger AK, Schulman KA, Gersh BJ et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999;282:341–348.

    Article  PubMed  CAS  Google Scholar 

  10. Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002;360:1623–1630.

    Article  PubMed  CAS  Google Scholar 

  11. Krumholz HM, Radford MJ, Ellerbeck EF et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes. Ann Intern Med 1996;124:292–298.

    PubMed  CAS  Google Scholar 

  12. Flather MD, and coll. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIOR study). European Heart Journal (2005) 26, 215–225.

    Article  PubMed  CAS  Google Scholar 

  13. Fox KM. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782–788.

    Article  PubMed  CAS  Google Scholar 

  14. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 2003;290:86–97.

    Article  PubMed  Google Scholar 

  15. « Traité de médecine cardiovasculaire du sujet âgé », Assayag, Davy et coll.; ed Médecine-Sciences, Flammarion 2007.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gérontopôle, CHU de Toulouse, France

    O. Toulza

Authors
  1. O. Toulza
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Philippe Chassagne Yves Rolland Bruno Vellas

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag France

About this chapter

Cite this chapter

Toulza, O. (2009). Prise den charge de la cardiopathie ischémique du sujet âgé fragile. In: Chassagne, P., Rolland, Y., Vellas, B. (eds) La personne âgée fragile. Springer, Paris. https://doi.org/10.1007/978-2-287-93911-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-93911-2_25

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-93910-5

  • Online ISBN: 978-2-287-93911-2

Publish with us

Policies and ethics

Search

Navigation